Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs

Details for Australian Patent Application No. 2012216643 (hide)

Owner Medipost Co., Ltd.

Inventors Chang, Jong Wook; Kim, Dal-Soo; Yang, Yoon-Sun; Oh, Won Il

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012216643

Parent 2008293208

Filing date 30 August 2012

Wipo publication date 20 September 2012

International Classifications

A61K 35/44 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Eyes

Event Publications

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216643

20 September 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216644-Ocular implant made by a double extrusion process

2012216642-Mutated pseudomonas exotoxins with reduced antigenicity